Immuneering Appoints Andrew Gengos as Chief Financial Officer
Go back to Immuneering Appoints Andrew Gengos as Chief Financial Officer| ImaRx Therapeutics, Inc. (NASDAQ: IMRX) | Delayed: 3.94 +0.20 (5.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.74 | 52 Week High | $0.04 | |||
| Open | $3.75 | 52 Week Low | $0.00 | |||
| Day High | $3.96 | P/E | N/A | |||
| Day Low | $3.68 | EPS | $-0.09 | |||
| Volume | 709,719 | |||||



